Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 230,296,497 papers from all fields of science
Search
Sign In
Create Free Account
Polychondritis, Relapsing
Known as:
Atrophic Polychondritis, Chronic
, Polychondritides, Chronic Atrophic
, Atrophic Polychondritides, Chronic
Expand
An acquired disease of unknown etiology, chronic course, and tendency to recur. It is characterized by inflammation and degeneration of cartilage and…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
10 relations
Broader (1)
Chronic inflammation
Dapsone
Dapsone 0.05 MG/MG Topical Gel
In Blood
Microbiological
Expand
Narrower (1)
Meyenburg-Altherr-Uehlinger syndrome
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2010
Review
2010
Hemodynamic patterns of chronic cerebrospinal venous insufficiency in multiple sclerosis. Correlation with symptoms at onset and clinical course.
I. Bartolomei
,
F. Salvi
,
+5 authors
P. Zamboni
International Angiology
2010
Corpus ID: 39945652
AIM Chronic cerebrospinal venous insufficiency (CCSVI) is associated with multiple sclerosis (MS). CCSVI is detected by…
Expand
Highly Cited
2006
Highly Cited
2006
Sequential maintenance treatment with glatiramer acetate after mitoxantrone is safe and can limit exposure to immunosuppression in very active, relapsing remitting multiple sclerosis
J. Ramtahal
,
A. Jacob
,
K. Das
,
M. Boggild
Journal of Neurology
2006
Corpus ID: 15901340
Mitoxantrone has been approved by the FDA for worsening relapsing remitting and secondary progressive Multiple Sclerosis. However…
Expand
2002
2002
Acute interferon β-1b administration alters hypothalamic-pituitary-adrenal axis activity, plasma cytokines and leukocyte distribution in healthy subjects
M. Goebel
,
Jan Baase
,
+4 authors
Volker Limmroth
Psychoneuroendocrinology
2002
Corpus ID: 20123262
Review
2000
Review
2000
Prevalence of multiple sclerosis in the L'Aquila district, central Italy
R. Totaro
,
C. Marini
,
Agostino Cialfi
,
M. Giunta
,
A. Carolei
Journal of Neurology Neurosurgery & Psychiatry
2000
Corpus ID: 26029906
OBJECTIVE To estimate the prevalence of multiple sclerosis in the L'Aquila district, central Italy. METHODS All available case…
Expand
Highly Cited
1997
Highly Cited
1997
Nasal administration of myelin basic protein prevents relapsing experimental autoimmune encephalomyelitis in DA rats by activating regulatory cells expressing IL-4 and TGF-β mRNA
X. Bai
,
F. Shi
,
B. Xiao
,
Hulun Li
,
P. Meide
,
H. Link
Journal of Neuroimmunology
1997
Corpus ID: 34473979
Review
1996
Review
1996
Peritonitis associated with exit site and tunnel infections.
B. Gupta
,
J. Bernardini
,
B. Piraino
American Journal of Kidney Diseases
1996
Corpus ID: 45940436
1995
1995
Cobalt-55 positron emission tomography in relapsing-progressive multiple sclerosis
J. Korf
,
H. Jansen
,
+7 authors
J. Minderhoud
Journal of Neurological Sciences
1995
Corpus ID: 23465084
Highly Cited
1991
Highly Cited
1991
Location of a new encephalitogenic epitope (residues 43 to 64) in proteolipid protein that induces relapsing experimental autoimmune encephalomyelitis in PL/J and (SJL x PL)F1 mice.
R. Whitham
,
R. Jones
,
+4 authors
H. Offner
Journal of Immunology
1991
Corpus ID: 37183916
Synthetic peptides of proteolipid protein (PLP) were screened for their ability to induce experimental autoimmune…
Expand
Highly Cited
1987
Highly Cited
1987
Myelin proteolipid protein induces demyelinating disease in mice
J. Trotter
,
H. Clark
,
K. Collins
,
Cindy L. Wegeschiede
,
J. D. Scarpellini
Journal of Neurological Sciences
1987
Corpus ID: 42403681
Highly Cited
1976
Highly Cited
1976
LEVAMISOLE IN PREVENTION OF RECURRENT UPPER-RESPIRATORY-TRACT INFECTIONS IN CHILDREN
M. Eygen
,
P. Y. Znamensky
,
E. Heck
,
I. Raymaekers
The Lancet
1976
Corpus ID: 24218378
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE